Overview Topical Aprepitant in Prurigo Patients Status: Completed Trial end date: 2014-07-01 Target enrollment: Participant gender: Summary Topical Aprepitant in Prurigo Patients - An Exploratory Phase IIa Trial With Topically Applied Aprepitant in Patients With Prurigo Phase: Phase 2 Details Lead Sponsor: LEO PharmaTreatments: AprepitantFosaprepitant